A detailed history of Point72 (Difc) LTD transactions in Fibrogen Inc stock. As of the latest transaction made, Point72 (Difc) LTD holds 52,254 shares of FGEN stock, worth $16,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,254
Previous 6,264 734.2%
Holding current value
$16,721
Previous $14.7 Million 216.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.89 - $2.36 $40,931 - $108,536
45,990 Added 734.2%
52,254 $46.6 Million
Q1 2024

May 15, 2024

BUY
$0.73 - $2.73 $4,572 - $17,100
6,264 New
6,264 $14.7 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $30M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.